Your browser doesn't support javascript.
loading
A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson's Disease.
Margolin, David H; Brice, Nicola L; Davidson, Antonia M; Matthews, Kim L; Carlton, Mark B L.
Afiliação
  • Margolin DH; Cerevance, Inc., Boston, Massachusetts (D.H.M.); Cerevance, Ltd., Cambridge, United Kingdom (N.L.B., K.L.M., M.B.L.C.); and Development, LP, Austin, Texas (A.M.D., P.P.D.).
  • Brice NL; Cerevance, Inc., Boston, Massachusetts (D.H.M.); Cerevance, Ltd., Cambridge, United Kingdom (N.L.B., K.L.M., M.B.L.C.); and Development, LP, Austin, Texas (A.M.D., P.P.D.).
  • Davidson AM; Cerevance, Inc., Boston, Massachusetts (D.H.M.); Cerevance, Ltd., Cambridge, United Kingdom (N.L.B., K.L.M., M.B.L.C.); and Development, LP, Austin, Texas (A.M.D., P.P.D.).
  • Matthews KL; Cerevance, Inc., Boston, Massachusetts (D.H.M.); Cerevance, Ltd., Cambridge, United Kingdom (N.L.B., K.L.M., M.B.L.C.); and Development, LP, Austin, Texas (A.M.D., P.P.D.).
  • Carlton MBL; Cerevance, Inc., Boston, Massachusetts (D.H.M.); Cerevance, Ltd., Cambridge, United Kingdom (N.L.B., K.L.M., M.B.L.C.); and Development, LP, Austin, Texas (A.M.D., P.P.D.) mark.carlton@cerevance.com.
J Pharmacol Exp Ther ; 381(1): 33-41, 2022 04.
Article em En | MEDLINE | ID: mdl-35110393
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Receptores Acoplados a Proteínas G Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Receptores Acoplados a Proteínas G Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article